PAOG Announces CRO Agreement To Advance Respiratory Cannabis Treatment Through Regulatory Approval

PAO Group, Inc. (USOTC: PAOG) today announced executing a master services agreement with a clinical research organization in the U.S. to prepare PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG signed the agreement yesterday, prior to the comprehensive corporate update scheduled for publication today and included in its entirety below. Source:…

Read More

PAOG FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday

PAO Group, Inc. (USOTC: PAOG) today announced the company plans to release a new key update this Friday, October 23, 2020, on its progress to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG announced last week that it anticipates soon entering into an agreement with a contract research organization (CRO) making a major…

Read More

PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness

Sandusky, Ohio–(Newsfile Corp. – October 16, 2020) – PAO Group, Inc. (OTC Pink: PAOG) and Puration, Inc. (OTC Pink: PURA) today announced a free hemp seed giveaway in conjunction with the recent partnership between the two companies where PAOG will be building a hemp cultivation facility on PURA’s Farmersville, Texas property. HEMPTo view an enhanced version of this graphic, please…

Read More

Is This $375 Million Cannabis Stock Too Good to Be True?

Following the industry bear market of 2019, many thought cannabis stocks would recover. Then came the coronavirus pandemic. Today, valuations remain 80% below their peak. Marijuana companies are still hurting. Just look at Hexo (TSX:HEXO)(NYSE:HEXO). This $375 million business was once valued at $2 billion! But this is far from the end. Marijuana consumption continues to rise, and companies are figuring…

Read More

Here Are 3 TSX Stocks to Sell if Joe Biden Becomes President

United States citizens and international onlookers were treated to the first debate between U.S. president Donald Trump and his challenger Democratic nominee Joe Biden on September 29. Last month, I’d discussed how a chaotic U.S. election could have a negative impact on domestic and global equities. The debate was one of the wildest and most contentious in modern history. Regardless,…

Read More

PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND

Sandusky, Ohio–(Newsfile Corp. – October 1, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced engaging Saul Kaye, the founder of iCAN (www.israel-cannabis.com) and CannaTech (www.canna-tech.co) to provide an independent review of PAOG’s RespRx research for the treatment of Chronic Obstructive Pulmonary Disease (COPD), and to help prepare RespRx for engaging with a contract research organization (CRO) to advance…

Read More

1 Pot Stock to Buy Before the Next Surge

Pot stocks had a heyday in 2018. That year, cannabis companies saw their shares double, triple, or even quadruple in price. The industry minted countless millionaires in a handful of months. Things changed quickly. In 2019, cannabis stocks entered a rough bear market. The coronavirus pandemic of 2020 pushed valuations even lower. Right now, many marijuana investors are jaded and…

Read More

PAOG Expands Cannabis Pharma Treatment Research

Sandusky, Ohio–(Newsfile Corp. – September 24, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced the company will expand its cannabis pharmaceutical treatment research beyond its current focus on Chronic Obstructive Pulmonary Disease (COPD).On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for COPD derived from a patented…

Read More